Synthesis and biological activity of a potent dual-acting platelet-activating factor and 5-lipoxygenase inhibitor.

被引：0

作者：

Hussoin, MS ^{[1
]}

Biftu, T ^{[1
]}

Cai, X ^{[1
]}

Scannell, RT ^{[1
]}

Grewal, G ^{[1
]}

Young, M ^{[1
]}

Yaeger, D ^{[1
]}

Killian, DB ^{[1
]}

Wypij, D ^{[1
]}

Lobell, R ^{[1
]}

Eckman, J ^{[1
]}

LibertineGraham, L ^{[1
]}

Qian, CG ^{[1
]}

Yeh, CG ^{[1
]}

机构：

[1] CYTOMED INC,CAMBRIDGE,MA 02139

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1996年 / 211卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：205 / MEDI

页数：1

共 50 条

[11] SYNTHESIS OF CHIRAL ZILEUTON, A POTENT AND SELECTIVE INHIBITOR OF 5-LIPOXYGENASE
HSIAO, CN
KOLASA, T
TETRAHEDRON LETTERS, 1992, 33 (19) : 2629 - 2632
[12] SYNTHESIS OF CHIRAL ZILEUTON, A POTENT AND SELECTIVE INHIBITOR OF 5-LIPOXYGENASE
HSIAO, CN
KOLASA, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 442 - ORGN
[13] Synthesis of CMI-977, a potent 5-lipoxygenase inhibitor
Cai, X
Chorghade, MS
Fura, A
Grewal, GS
Jauregui, KA
Lounsbury, HA
Scannell, RT
Yeh, CG
Young, MA
Yu, SX
Guo, L
Moriarty, RM
Penmasta, R
Rao, MS
Singhal, RK
Song, ZZ
Staszewski, JP
Tuladhar, SM
Yang, SM
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (01) : 73 - 76
[14] LIPOXYGENASE INHIBITOR EFFECTS THE BIOSYNTHESIS OF PLATELET-ACTIVATING FACTOR IN BOVINE POLYMORPHONUCLEAR NEUTROPHILS
REMY, E
LENOIR, G
HOUBEN, A
REMACLE, J
ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1987, 95 (05): : B231 - B231
[15] Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway
Urasaki, T
Takasaki, J
Nagasawa, T
Ninomiya, H
JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (01) : 105 - 112
[16] Eugenol: A dual inhibitor of platelet-activating factor and arachidonic acid metabolism
Saeed, SA
Simjee, RU
Shamim, G
Gilani, AH
PHYTOMEDICINE, 1995, 2 (01) : 23 - 28
[17] INHIBITION OF ENDOTOXIN-INDUCED MICROVASCULAR LEAKAGE BY A PLATELET-ACTIVATING-FACTOR ANTAGONIST AND 5-LIPOXYGENASE INHIBITOR
KLABUNDE, RE
CALVELLO, C
SHOCK, 1995, 4 (05): : 368 - 372
[18] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SOME ISOMERIC STRUCTURE ANALOGS OF THE PLATELET-ACTIVATING FACTOR
KERTSCHER, HP
OSTERMANN, G
PHARMAZIE, 1985, 40 (01): : 55 - 56
[19] Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity
Serradji, N
Martin, M
Bensaid, O
Cisternino, S
Rousselle, C
Dereuddre-Bosquet, N
Huet, J
Redeuilh, C
Lamouri, A
Dong, CZ
Clayette, P
Scherrmann, JM
Dormont, D
Heymans, F
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) : 6410 - 6419
[20] Design, synthesis and biological activities of new potent factor XA inhibitor.
Nishida, H
Mukaihira, T
Saitoh, F
Hosaka, Y
Matsusue, T
Shiromizu, I
Kamiya, M
Naba, H
Ohnishi, S
Mochizuki, H
Yanagibashi, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U953 - U953

← 1 2 3 4 5 →